
Five components, taken in order. Each builds directly on the one before it, and together they cover every injection target used in therapeutic oro-facial pain practice — masseter, temporalis, frontalis, corrugator, procerus, occipitalis, cervical paraspinals and trapezius.
Pharmacology, serotypes, mechanism of action, storage, contraindications, consent and complication management.
Open Foundation Botox courseReconstitution volumes, unit conversion between products and dilution for diffusion control — critical when a single therapeutic session may involve 100–195 units across many sites.
Open Dilution & Reconstitution courseCorrugator, procerus and frontalis. Required for oro-facial pain because the anterior PREEMPT sites are upper-face sites, and because tension-type headache frequently involves the glabellar complex.
Open Upper Face Botox courseMasseter anatomy, the three-point technique, dosing for bruxism versus cosmetic slimming, avoiding paradoxical bulge and risorius diffusion. Includes foundation and dilution content, but not upper face — which is why Step 3 remains mandatory.
Open Masseter Botox courseICHD-3 diagnosis, patient selection, 31 fixed sites at 155 U, follow-the-pain add-on to 195 U, NICE TA260 and the PREEMPT versus PRECLUDE evidence base.
View the migraine pathwayA critical review of the PREEMPT protocol and the evidence for botulinum toxin in migraine prevention, published in Aesthetic Intelligence.
Read the reviewOro-facial pain is where therapeutic botulinum toxin earns its place in medical and dental practice. Bruxism, temporomandibular dysfunction, masticatory myalgia and chronic migraine overlap constantly in the same patient population — and, conveniently, so do their injection targets.
A patient presenting with morning jaw ache, tooth wear, temporal headache and fifteen headache days a month is not four separate problems. They are one clinical picture, treatable through a coherent sequence of botulinum toxin protocols that share pharmacology, dilution logic and anatomy.
This pathway assembles the five components required to treat that picture competently: fundamentals of botulinum toxin, dilution and reconstitution, upper face injection, masseter injection, and the PREEMPT chronic migraine protocol. Each is delivered online and each carries AiCE Points on completion.
Dentists in particular see more bruxism, tooth surface loss and TMJ dysfunction than any other professional group. The pathway is deliberately structured so that a dentist with no aesthetic background can start at Step 1 and finish with a defensible therapeutic protocol.
Botox for oro-facial pain is the therapeutic administration of botulinum toxin type A to reduce masticatory muscle hyperactivity, myofascial pain and trigeminal nociceptive input. It is distinct from aesthetic injection in intent, dosing and outcome measurement.
In masseter and temporalis treatment, the mechanism is largely neuromuscular — reduced parafunctional clenching force, reduced muscle bulk over successive cycles, and reduced myalgia. In chronic migraine, the mechanism is sensory: reduction in peripheral CGRP release and nociceptive afferent traffic at trigeminal and cervical terminals, not muscular relaxation.
Understanding that distinction is the single most important conceptual step in this pathway. It determines dose, depth, site selection and the outcome measures used to judge whether treatment has worked.
Oro-facial pain patients rarely arrive with a single tidy diagnosis. Specialist training builds the diagnostic sequence that determines which protocol applies, and in what order.
Masseter injection at the wrong depth produces paradoxical bulging or risorius diffusion and an asymmetric smile. Temporalis injection without regard for the superior temporal line produces disappointing results. Migraine injection outside the licensed indication produces no benefit and no funding.
None of these are difficult techniques. They are simply techniques with rules, and the rules are only learned deliberately.
This pathway is designed for doctors, dentists, nurse prescribers and pharmacist prescribers who wish to add therapeutic botulinum toxin to their practice.
Dentists are the natural constituency. Bruxism, tooth surface loss and TMJ dysfunction present in dental chairs every day, and the anatomy is already familiar. What is usually missing is the pharmacology, dilution discipline and injection protocol — precisely what this pathway supplies.
Patient selection determines outcome more than technique. Masticatory myalgia responds well to masseter and temporalis injection; internal derangement of the temporomandibular joint does not, and requires referral.
Chronic migraine must be confirmed against ICHD-3 criteria — at least fifteen headache days per month, of which at least eight are migraine days, sustained over three months. Episodic migraine is a different condition, and the PRECLUDE trial was negative at both 155 and 195 units.
Where medication overuse headache is present, it must be addressed before botulinum toxin is appraised. Injecting into an unaddressed overuse picture produces an uninterpretable result.
The oro-facial pain pathway is the therapeutic counterpart to the Harley Street Institute botox masterclass programme. Where the masterclasses develop aesthetic judgement, this pathway develops therapeutic reasoning.
Practitioners frequently complete both. The overlap in anatomy is substantial, and the combination supports a broader, more defensible scope of practice.
Every component is delivered online and self-paced, with video demonstration, anatomical reference and gated assessment. AiCE Points are awarded on successful completion.
Practitioners who wish to add supervised hands-on experience can combine the pathway with a practical masterclass day in London or Manchester.
Opens in new window - External learning platform
Therapeutic botulinum toxin must be delivered within scope of practice, with indemnity that explicitly covers therapeutic indications. Aesthetic-only indemnity is not sufficient.
Documentation should record the diagnostic basis for treatment, baseline and follow-up outcome measures, and the consent discussion covering off-label use where applicable.
Completed in sequence, this pathway takes a practitioner from first principles of botulinum toxin through to defensible therapeutic treatment of bruxism, TMJ dysfunction, masticatory myalgia and chronic migraine.
Start at Step 1 if you are new to botulinum toxin. If you already hold foundation training, begin at Step 3 and work forward.
Continue your training
Complementary courses from the Harley Street Institute clinical faculty.
Explore the full HSI advanced Botox curriculum for medical professionals.
Foundation to fellowship-level Botox training pathways.
The essential clinical grounding before specialist masterclasses.
From the journal
Harley Street Institute training aligns with the standards set by the UK regulators and professional associations below.
External links open in a new tab. Outbound references are provided for verification only and do not imply endorsement of HSI by the linked organisation.
Flexible payment options
Choose from trusted providers at checkout. Whether you prefer to pay in full, split across instalments, or pay later, the option is yours — secured by industry-standard providers.
Klarna availability subject to eligibility checks at checkout. Stripe and PayPal available for all major cards. Course fees may be split into instalments where supported.
Flexible payment options
Choose from trusted providers at checkout. Whether you prefer to pay in full, split across instalments, or pay later, the option is yours — secured by industry-standard providers.
Klarna availability subject to eligibility checks at checkout. Stripe and PayPal available for all major cards. Course fees may be split into instalments where supported.